Lineage Inc
For the period ended Jun 30, 2024. Filed Aug 21, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 21, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Derivative instruments and hedging activities
(10)Derivative instruments and hedging activities
(a)Risk management objective of using derivatives
The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, foreign currency, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and with the use of derivative financial instruments.
(b)Cash flow hedges of interest rate and foreign currency risk
The Company’s objectives in using interest rate derivatives are to manage its exposure to interest rate movements and to mitigate the potential volatility to interest expense. To accomplish this objective, the Company primarily uses interest rate swaps and caps as part of its interest rate risk management strategy. Interest rate swaps involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Interest rate caps involve the receipt of variable amounts from a counterparty if interest rates rise above the strike rate on the contract in exchange for a premium. The Company’s designated interest rate swaps and caps hedge variable-rate interest payments using a first payments approach. The first payments approach allows an entity to hedge interest payments on a designated principal amount, rather than a specific, named debt issuance. Refer to Note 9, Debt for additional information.
In addition, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future cash amounts due to changes in foreign currency rates.
(c)Designated hedges
As of June 30, 2024, the Company had the following outstanding interest rate and foreign currency derivatives that were designated as cash flow hedging instruments:
| Number of Instruments · Notional(in millions) | |||
|---|---|---|---|
| Interest rate derivatives: | |||
| Interest rate swap | 2 | USD | 1,000 |
| Interest rate cap | 3 | USD | 1,500 |
| Total | 5 | USD | 2,500 |
| (in millions) · Buy Notional · Sell Notional | ||||
|---|---|---|---|---|
| Foreign currency derivatives: | ||||
| Buy EUR/Sell GBP forward | EUR | 24 | GBP | 21 |
| Buy USD/Sell GBP forward | USD | 5 | GBP | 4 |
The tables below presents the effect of the Company’s derivatives that are designated as hedging instruments on the accompanying condensed consolidated statements of operations and comprehensive income (loss) (in millions).
| Derivatives in Cash Flow Hedging Relationships · Amount of Gain (Loss) Recognized in OCI on Derivatives · Location of Gain (Loss) Reclassified from Accumulated OCI into Earnings · Amount of Gain (Loss) Reclassified from Accumulated OCI into Earnings | |||||
|---|---|---|---|---|---|
| Three Months Ended June 30, · Three Months Ended June 30, | |||||
| 2024 · 2023 · 2024 · 2023 | |||||
| Included in effectiveness testing: | |||||
| Interest rate contracts | $11 | $54 | Interest expense, net | $25 | $30 |
| Foreign exchange contracts | (1) | — | Gain (loss) on foreign currencytransactions, net | (2) | — |
| Excluded from effectiveness testing and recognized in earnings based on an amortization approach: | |||||
| Interest rate contracts | — | (4) | Interest expense, net | — | (1) |
| Total | $10 | $50 | $23 | $29 | |
| Derivatives in Cash Flow Hedging Relationships · Amount of Gain (Loss) Recognized in OCI on Derivatives · Amount of Gain (Loss) Reclassified from Accumulated OCI into Earnings · Amount of Gain (Loss) Reclassified from Accumulated OCI into Earnings | |||||
|---|---|---|---|---|---|
| Six Months Ended June 30, · Six Months Ended June 30, | |||||
| 2024 · 2023 · 2024 · 2023 | |||||
| Included in effectiveness testing: | |||||
| Interest rate contracts | $43 | $39 | Interest expense, net | $51 | $55 |
| Foreign exchange contracts | (1) | (1) | Gain (loss) on foreign currencytransactions, net | (1) | — |
| Excluded from effectiveness testing and recognized in earnings based on an amortization approach: | |||||
| Interest rate contracts | (3) | (4) | Interest expense, net | (1) | (1) |
| Total | $39 | $34 | $49 | $54 | |
The estimated net amount of existing gains (losses) that are reported in Accumulated other comprehensive income (loss) as of June 30, 2024 that is expected to be reclassified into earnings within the next 12 months is $88 million.
(d)Non-designated hedges
As of June 30, 2024, the Company had the following outstanding derivatives that were not designated as hedging instruments:
| Number of Instruments · Notional(in millions) | |||
|---|---|---|---|
| Interest Rate Derivatives | |||
| Interest rate cap | 7 | USD | 1,320 |
The tables below presents the effect of the Company’s derivative financial instruments that are not designated as hedging instruments on the condensed consolidated statements of operations and comprehensive income (loss) (in millions).
| Derivatives Not Designated as Hedging Instruments · Location of Gain (Loss) Recognized in Earnings on Derivatives · Amount of Gain (Loss) Recognized in Earnings on Derivatives | |||
|---|---|---|---|
| Three Months Ended June 30, | |||
| 2024 · 2023 | |||
| Interest rate contracts | Interest expense, net | $— | $4 |
| Total | $— | $4 | |
| Derivatives Not Designated as Hedging Instruments · Location of Gain (Loss) Recognized in Earnings on Derivatives · Amount of Gain (Loss) Recognized in Earnings on Derivatives | |||
|---|---|---|---|
| Six Months Ended June 30, | |||
| 2024 · 2023 | |||
| Interest rate contracts | Interest expense, net | $— | $3 |
| Total | $— | $3 | |
The table below presents the fair value of the Company’s derivative financial instruments as well as their classification in the condensed consolidated balance sheets as of:
| (in millions) | June 30, 2024 | December 31, 2023 | June 30, 2024 | December 31, 2023 |
|---|---|---|---|---|
| Derivatives designated as hedging instruments | ||||
| Balance sheet location | Other assets | Other assets | Other liabilities | Other liabilities |
| Interest rate contracts | $124 | $135 | $— | $— |
| Total | $124 | $135 | $— | $— |
| Derivatives NOT designated as hedging instruments | ||||
| Balance sheet location | Other assets | Other assets | Other liabilities | Other liabilities |
| Interest rate contracts | $— | $3 | $— | $— |
| Foreign exchange contracts | — | — | — | (1) |
| Total | $— | $3 | $— | $(1) |
The notional value of the Company’s non-designated foreign currency derivatives is immaterial. Refer to Note 12, Fair value measurements for further information on the valuation of the Company’s derivatives.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.